The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia

FASEB Journal

Volumn 23, Issue 8, 2009, Pages 2403-2411

  Yende, Sachin ^a   Angus, Derek C ^a   Kong, Lan ^a,b   Kellum, John A ^a   Weissfeld, Lisa ^a,b   Ferrell, Robert ^b   Finegold, David ^b   Carter, Melinda ^a   Leng, Lin ^c   Peng, Zhi Yong ^a   Bucala, Richard ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Innate immunity; Sepsis; TNF

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; ISOMERASE; MICROSATELLITE DNA; MIF PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HAZARD RATIO; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SEPSIS; COMMUNICABLE DISEASE; GENE FREQUENCY; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; KAPLAN MEIER METHOD; MIDDLE AGED; PNEUMONIA; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GENE FREQUENCY; HUMANS; IMMUNITY, INNATE; INTRAMOLECULAR OXIDOREDUCTASES; KAPLAN-MEIERS ESTIMATE; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PNEUMONIA; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SEPSIS;

EID: 68849109968     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-129445     Document Type: Article

References (42)

1. Calandra, T., and Roger, T. (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800 (Pubitemid 37328657)
2. Cohen, J., Guyatt, G., Bernard, G. R., Calandra, T., Cook, D., Elbourne, D., Marshall, J., Nunn, A., and Opal, S. (2001) New strategies for clinical trials in patients with sepsis and septic shock. Crit. Care Med. 29, 880-886 (Pubitemid 32299732)
3. Morand, E. F., Leech, M., Weedon, H., Metz, C., Bucala, R., and Smith, M. D. (2002) Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology (Oxford) 41, 558-562 (Pubitemid 34567187)
4. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter,W., Manogue, K. R., Cerami, A., and Bucala, R. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756-759 (Pubitemid 23339882)
5. Calandra, T., Spiegel, L. A., Metz, C. N., and Bucala, R. (1998) Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria. Proc. Natl. Acad. Sci. U. S. A. 95, 11383-11388 (Pubitemid 28450137)
6. Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hultner, L., Heumann, D., Mannel, D., Bucala, R., and Glauser, M. P. (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6, 164-170 (Pubitemid 30082360)
7. Bozza, M., Satoskar, A. R., Lin, G., Lu, B., Humbles, A. A., Gerard, C., and David, J. R. (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189, 341-346 (Pubitemid 29063255)
8. Beishuizen, A., Thijs, L. G., Haanen, C., and Vermes, I. (2001) Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J. Clin. Endocrinol. Metab. 86, 2811-2816 (Pubitemid 32545744)
9. Lehmann, L. E., Novender, U., Schroeder, S., Pietsch, T., von Spiegel, T., Putensen, C., Hoeft, A., and Stuber, F. (2001) Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intens. Care Med. 27, 1412-1415 (Pubitemid 32758941)
10. Bozza, F. A., Gomes, R. N., Japiassu, A. M., Soares, M., Castro- Faria-Neto, H. C., Bozza, P. T., and Bozza, M. T. (2004) Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 22, 309-313 (Pubitemid 39480698)
11. Gando, S., Nishihira, J., Kobayashi, S., Morimoto, Y., Nanzaki, S., and Kemmotsu, O. (2001) Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intens. Care Med. 27, 1187-1193 (Pubitemid 32710206)
12. Koebernick, H., Grode, L., David, J. R., Rohde, W., Rolph, M. S., Mittrucker, H. W., and Kaufmann, S. H. (2002) Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 99, 13681-13686 (Pubitemid 35215441)
13. Honma, N., Koseki, H., Akasaka, T., Nakayama, T., Taniguchi, M., Serizawa, I., Akahori, H., Osawa, M., and Mikayama, T. (2000) Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 100, 84-90 (Pubitemid 30242886)
14. Satoskar, A. R., Bozza, M., Rodriguez, S. M., Lin, G., and David, J. R. (2001) Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. 69, 906-911 (Pubitemid 32109555)
15. Pollak, N., Sterns, T., Echtenacher, B., and Mannel, D. N. (2005) Improved resistance to bacterial superinfection in mice by treatment with macrophage migration inhibitory factor. Infect. Immun. 73, 6488-6492 (Pubitemid 41368811)
16. Donn, R. P., Shelley, E., Ollier, W. E., and Thomson, W. (2001) A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 44, 1782-1785 (Pubitemid 32758224)
17. Baugh, J. A., Chitnis, S., Donnelly, S. C., Monteiro, J., Lin, X., Plant, B. J., Wolfe, F., Gregersen, P. K., and Bucala, R. (2002) A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 3, 170-176 (Pubitemid 38961128)
18. Donn, R., Alourfi, Z., Zeggini, E., Lamb, R., Jury, F., Lunt, M., Meazza, C., De Benedetti, F., Thomson, W., and Ray, D. (2004) A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum. 50, 1604-1610 (Pubitemid 38608083)
19. Radstake, T. R., Sweep, F. C., Welsing, P., Franke, B., Vermeulen, S. H., Geurts-Moespot, A., Calandra, T., Donn, R., and van Riel, P. L. (2005) Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 52, 3020-3029 (Pubitemid 41447081)
20. Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld L. A., Singer, D. E., Coley, C. M., Marrie, T. J., and Kapoor, W. N. (1997) A prediction rule to identify low-risk patients with community acquired pneumonia. N. Engl. J. Med. 336, 243-250 (Pubitemid 27044625)
21. Zhong, X. B., Leng, L., Beitin, A., Chen, R., McDonald, C., Hsiao, B., Jenison, R. D., Kang, I., Park, S. H., Lee, A., Gregersen, P., Thuma, P., Bray-Ward, P., Ward, D. C., and Bucala, R. (2005) Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res. 33, e121 (Pubitemid 41487307)
22. Charlson, M. E., Pompei, P., Ales, K. L., and MacKenzie, C. R. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40, 373-383 (Pubitemid 17055592)
23. Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., Bastos, P. G., Sirio, C. A., Murphy, D. J., Lotring, T., and Damiano, A. (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100, 1619-1636
24. Levy, M. M., Fink, M., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J. L., and Ramsay, G. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care. Med. 31, 1250-1256 (Pubitemid 36444440)
25. National Death Index. http://www.cdc.gov/nchs/ndi.htm (Accessed November 2008).
26. Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Jr., Musher, D. M., Niederman, M. S., Torres, A., and Whitney, C. G. (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44(Suppl 2), S27-S72 (Pubitemid 46290553)
27. Holmes, C. L., Russell, J. A., and Walley, K. R. (2003) Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124, 1103-1115
28. Kellum, J. A., Kong, L., Fink, M. P., Weissfeld, L. A., Yealy, D. M., Pinsky, M. R., Fine, J., Krichevsky, A., Delude, R. L., Angus, D. C., and for the GenIMS Investigators (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the genetic and inflammatory markers of sepsis (GenIMS) study. Arch. Intern. Med. 167, 1655-1663
29. Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., and Muller, B. (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363, 600-607 (Pubitemid 38264177)
30. Donn, R., Alourfi, Z., De Benedetti, F., Meazza, C., Zeggini, E., Lunt, M., Stevens, A., Shelley, E., Lamb, R., Ollier, W. E., Thomson, W., and Ray, D. (2002) Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 46, 2402-2409
31. Hochberg, Y., and Benjamini, Y. (1990) More powerful procedures for multiple significance testing. Stat. Med. 9, 811-818 (Pubitemid 20343989)
32. Laird, N. M., and Ware, J. H. (1982) Random-effects models for longitudinal data. Biometrics 38, 963-974
33. Meyer-Siegler, K. L., Vera, P. L., Iczkowski, K. A., Bifulco, C., Lee, A., Gregersen, P. K., Leng, L., and Bucala, R. (2007) Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun. 8, 646-652 (Pubitemid 350238434)
34. Guyatt, G. H., Sackett, D. L., Sinclair, J. C., Hayward, R., Cook, D. J., and Cook, R. J. (1995) Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 274, 1800-1804
35. Metersky, M. L., Ma, A., Bratzler, D. W., and Houck, P. M. (2004) Predicting bacteremia in patients with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 169, 342-347 (Pubitemid 38134812)
36. Joshi, N., Caputo, G. M., Weitekamp, M. R., and Karchmer, A. W. (1999) Infections in patients with diabetes mellitus. N. Engl. J. Med. 341, 1906-1912
37. Reiner, A., Yekutieli, D., and Benjamini, Y. (2003) Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19, 368-375 (Pubitemid 36284936)
38. Gallagher, P. M., Lowe, G., Fitzgerald, T., Bella, A., Greene, C. M., McElvaney, N. G., and O'Neill, S. J. (2003) Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 58, 154-156 (Pubitemid 36183005)
39. Waterer, G. W., Quasney, M. W., Cantor, R. M., and Wunderink, R. G. (2001) Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am. J. Respir. Crit. Care Med. 163, 1599-1604
40. Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., and Bucala, R. (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 99, 345-350 (Pubitemid 34060365)
41. Roger, T., David, J., Glauser, M. P., and Calandra, T. (2001) MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414, 920-924 (Pubitemid 34024744)
42. Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., and Bucala, R. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71